Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERK 2: Ketotifen for Prevention of Posttraumatic Joint Contractures
NCT03582176Phase 3Completed
- Sponsor
- University of Calgary
- Start
- Apr 2019
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of ketotifen in Posttraumatic joint contracture (PTJC), sponsored by University of Calgary. Started Apr 2019; status: completed.
02
Drugs
ketotifen
03
Conditions
Posttraumatic joint contracture (PTJC)
Beyond the preview
Go deeper on NCT03582176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03582176.